Flunarizine in Migraine Prophylaxis: Efficacy and Tolerability of 5 mg and 10 mg Dose Levels
- 1 February 1990
- journal article
- research article
- Published by SAGE Publications in Cephalalgia
- Vol. 10 (1), 17-24
- https://doi.org/10.1046/j.1468-2982.1990.1001017.x
Abstract
The use of flunarizine, a drug which has proven its efficacy in migraine, is often associated with important side effects. The aim of this paper has been to check their incidence at different dose levels (5 mg vs 10 mg). Our data confirm the occurrence of important side effects (in particular weight gain); on the other hand, they emphasize the dose-dependency of the side effects.Keywords
This publication has 20 references indexed in Scilit:
- Flunarizine, a Calcium Channel Blocker, in the Prophylactic Treatment of MigraineHeadache: The Journal of Head and Face Pain, 2005
- Essential Tremor and Flunarizine: Description of a CaseCephalalgia, 1987
- PARKINSONISM, TARDIVE DYSKINESIA, AKATHISIA, AND DEPRESSION INDUCED BY FLUNARIZINEThe Lancet, 1986
- Flunarizine in Common Migraine Prophylaxis. A Doubl E-Blind, Cross-Over StudyCephalalgia, 1985
- Flunarizine Treatment in Migraine Syndrome: Long-Term Follow-Up in Common Migraine and Preliminary Results in Migraine with Interparoxysmal HeadacheCephalalgia, 1985
- Flunarizine in the Treatment of HeadacheCephalalgia, 1985
- The Pharmacology of Calcium Channel Antagonists: a Novel Class of Anti-migraine Agents?Headache: The Journal of Head and Face Pain, 1983
- Clinical Effectiveness of Calcium Entry Blockers in Prophylactic Treatment of Migraine and Cluster HeadachesHeadache: The Journal of Head and Face Pain, 1983
- Comparison of Flunarizine (Sibelium®) and Pizotifen (Sandomigran®) in Migraine Treatment: A Double-Blind StudyCephalalgia, 1982
- A Double‐blind Placebo‐controlled Prophylactic Study of Flunarizine (Sibelium®) in MigraineHeadache: The Journal of Head and Face Pain, 1981